Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Extensive Experience Remodels Neural Task Circuitry to Escape the Frontal Bottleneck and Increase Automaticity of Categorization
Neuroscience & Brain Research

Extensive Experience Remodels Neural Task Circuitry to Escape the Frontal Bottleneck and Increase Automaticity of Categorization

Rifan Muazin Jul 21, 2026 0

The long-held scientific consensus that the human brain is incapable of true multitasking is being challenged by new research from…

Read More
Neuroscience & Brain Research

Extensive Experience Remodels Neural Task Circuitry to Escape the Frontal Bottleneck and Increase Automaticity of Categorization.

Rifan Muazin Jul 13, 2026 0

This landmark conclusion, reached by a team of neuroscientists at Georgetown University, fundamentally alters the scientific community’s understanding of the…

Read More
Gut Microbiome Breakthrough Links Bacterial Sugars to ALS and Frontotemporal Dementia ProgressionBenchmarking Data Analysis Prowess: SQL, Pandas, and AI Agents Under ScrutinyScience News: A Centennial of Illuminating the World of ScienceTropical Butterflies Unveil Secrets to Extended Lifespan and Slowed Aging
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ